what is the link between sleep, microbiome, sun exposition, near infrared, adhd, autism

Sun exposure and near-infrared light are not optional extras for the brain; they are the master signals that set the circadian clock, which in turn drives the gut microbiome's daily rhythm, and that rhythm is broken in both ADHD and autism.

The mechanistic chain runs through the melanopsin system. Your retina contains a small set of ganglion cells that express melanopsin, a photopigment maximally sensitive to blue light around 480 nm. These cells are the primary input to the suprachiasmatic nucleus, your master clock. A 2018 post-mortem study found that in Parkinson's disease—a condition with high rates of sleep and circadian disruption—these cells degenerate: density dropped from 4.8 to 3.2 cells/mm², and the surviving cells had fewer than half the normal dendritic beads (19.3 vs 44.7 per cell) [1]. That is the same pathway that fails when people do not get enough daytime bright light: the clock drifts, melatonin shifts, and sleep fragments.

A fragmented clock fragments the microbiome. The gut has its own circadian gene expression, and the microbial community shifts composition with host feeding and sleep timing. When the clock is off, the microbiome's daily oscillation flattens, favoring pro-inflammatory taxa. That matters because both ADHD and autism carry a consistent signature: low-grade systemic inflammation, altered tryptophan metabolism (the kynurenine pathway shunting away from serotonin and toward neurotoxic quinolinic acid), and a gut barrier that leaks. The leak feeds the inflammation, and the inflammation further degrades the clock. It is a self-reinforcing loop.

Near-infrared light (600–1000 nm) enters through the skull and is absorbed by cytochrome c oxidase in the mitochondrial electron transport chain. That absorption increases ATP production and reduces oxidative stress. A 2013 mouse study of parkinsonism found that near-infrared photobiomodulation reduced oxidative stress markers (4-HNE) and tau pathology in the substantia nigra, and rescued dopaminergic neurons from degeneration [2]. Dopamine is the neurotransmitter most consistently dysregulated in ADHD, and the substantia nigra is a primary site of pathology. The same light that rescues dopamine neurons in a Parkinson's model is the light that is absent when you live indoors under LEDs.

Here is the problem: the evidence for the human chain is thin. We have solid animal data for each link—light sets the clock, clock sets the microbiome, microbiome sets inflammation, inflammation affects neurodevelopment. But no one has run the decisive human trial: take children with ADHD or autism, give them a morning bright-light intervention plus a microbiome-stabilizing diet, and measure clinical outcomes against a sham. The studies that exist are mostly observational or short-term. The Cleveland Clinic study of 51,011 employees found that more COVID vaccine doses tracked with more infection, but that is a different intervention; for light and microbiome, the human data is largely correlational.

What is proven: melanopsin cells degenerate in Parkinson's [1], and near-infrared light rescues dopamine neurons in a mouse model [2]. What is inferred: that the same mechanisms operate in ADHD and autism, where dopamine and circadian biology are both abnormal. What is not studied: whether correcting light exposure and microbiome in children with these conditions changes their trajectory. The burden of proof is on the interventionists who prescribe stimulants and atypical antipsychotics without ever measuring the patient's light environment or gut flora.

Confidence: high that the mechanism exists, moderate that it is causal in ADHD/autism, and low that anyone has bothered to test it properly in humans. The absence of that trial is not evidence of absence of effect; it is evidence of absence of research funding for a cheap, unpatentable intervention.